Abiopharma

🔍 Napoli Silvio (Director)

Company: Eaton Corp plc (ETN)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 621 shares of Ordinary Shares (Direct)
  Date: 2026-05-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,055.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 299 shares of Ordinary Shares at $416.5 per share (Direct)
  Date: 2026-05-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,756.00 | transaction_form_type: 4
• Sold 621 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F1, F2
• Acquired 470 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 470.00 | transaction_form_type: 4 | Footnotes: F4, F2

Footnotes:

• F1: The restricted stock units were granted to the reporting person as compensation for the reporting person's service as a member of the Issuer's Board of Directors and vested in their entirety on the first anniversary of the date of grant. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
• F2: This field is not applicable.
• F3: Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
• F4: The restricted stock units were granted to the reporting person as compensation for the reporting person's service as a member of the Issuer's Board of Directors. These restricted stock units will vest in their entirety on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
• F5: Shares have been adjusted to account for reinvested dividends.
• REMARKS: Power of Attorney is attached hereto as Exhibit 24.